LexDanaLexDanabeta
Inventor

Feng Ren

Inventor
Shanghai, CN

Overview

8→
Patents
2012–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 8 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07DHeterocyclic compounds36%
A61KPreparations for medical, dental or toiletry purposes18%
C07CAcyclic or carbocyclic compounds9%
PatentTitleYear
11,034,696Compounds for inhibiting LRRK2 kinase activity202110,858,367Compounds202010,336,7191-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors201910,106,5151-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors20189,902,715'Compounds'20189,868,724'Compounds'20188,389,508'Heterocyclic compounds'20138,217,028'1,2,4-oxadiazole indole compounds'2012

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2012–2013Patents assigned to GLAXO GROUP LTD (2)· patent assignee history
2012–2013Patents assigned to LIN XICHEN (2)· patent assignee history
2012–2013Patents assigned to REN FENG (2)· patent assignee history
2012–2013Patents assigned to ZHAO BAOWEI (2)· patent assignee history
2012–2021Based in Shanghai, CN· patent location history
2018–2021Patents assigned to GLAXOSMITHKLINE IP DEV LTD (6)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GLAXOSMITHKLINE IP DEV LTD62018–2021
GLAXO GROUP LTD22012–2013
LIN XICHEN22012–2013
REN FENGself22012–2013
ZHAO BAOWEI22012–2013
Locations
LocationPatentsSpan
Shanghai, CN82012–2021